Research protocols using 5-Amino-1MQ typically administer 50100mg daily via subcutaneous injection, based on human equivalent dose scaling from rodent studies where 10mg/kg bodyweight produced measurable NNMT suppression and increased NAD+ bioavailability
At the same time, copper itself is a required cofactor for several angiogenic enzymes and transcriptional programs, and the GHK peptide appears to deliver copper in a biologically functional form at sites of cellular injury
BPC-157 literature should be interpreted as research context, not product-use guidance
B12 injections are generally well-tolerated with mild injection site reactions, though rare hypersensitivity and hypokalaemia can occur, particularly when initiating treatment for severe deficiency
No but the stack logic is strongest when combined with a GLP-1 agonist creating a caloric deficit
If you worsen: what caused it